Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kirsten M. Reeves
Observed name:
Kirsten Reeves
Institutions:
University of Alabama at Birmingham,
O'Neal Comprehensive Cancer Center
Observed institutions:
University of Alabama at Birmingham,
UAB Medicine,
O'Neal Comprehensive Cancer Center
ORCID:
0000-0001-9199-1580
Observed ORCID:
0000-0001-9199-1580
OpenAlex ID:
A5085237292
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
2021
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
·
Clinical Cancer Research
·
69
Imaging for Response Assessment in Cancer Clinical Trials
2020
·
Anna G. Sorace
, Asser A. Elkassem
, et al.
·
Seminars in Nuclear Medicine
·
51
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response
2024
·
Kaytlyn C. McNeal
, Kirsten M. Reeves
, et al.
·
Nuclear Medicine and Biology
·
9
PDF
Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy
2023
·
Angela M. Jarrett
, Patrick N. Song
, et al.
·
Mathematical Biosciences
·
4
PDF
Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer
2023
·
Ernesto A. B. F. Lima
, Patrick N. Song
, et al.
·
Mathematical Biosciences & Engineering
·
3
PDF
Supplementary Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
2023
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
PDF
Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
2023
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
Supplementary Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
2023
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
2023
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
[18F]-FMISO PET imaging of tumor hypoxia to predict and monitor response to checkpoint inhibitor therapy.
2020
·
Kirsten M. Reeves
, Patrick N. Song
, et al.
·
Journal of Nuclear Medicine
Show more works
View as search
Works count:
10
Citation count:
136
H-index:
4
I10-index:
2
Year
Topic
Type